Physician

Yuba Raj Acharya, M.D.

According to 2025 Medicare claims, Yuba Acharya, M.D. (NPI: 1376716290) practices cardiology in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is CHI ST. VINCENT MEDICAL GROUP HOT SPRINGS (NPI: 1831387117; TIN: 261125131) and primary practice location at 71913-6406. Acharya is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and CommonSpirit ACO III (ACO ID: A2645), participating under the MSSP model.

Acharya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,268 traditional Medicare patients, billed 3,639 HCPCS/CPT codes, and received $200,102 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,583 prescription claims across 1,268 beneficiaries totaling $1,291,850 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 61 records totaling $1,108. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,450 to $1,291,850. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	469	1,154	$79,313
2016	1,361	3,912	$277,215
2017	1,797	5,398	$382,003
2018	1,629	5,146	$347,683
2019	1,663	5,159	$331,613
2020	1,340	4,210	$266,773
2021	1,276	3,829	$246,855
2022	1,354	4,050	$224,758
2023	1,286	4,006	$220,946
2024	1,268	3,639	$200,102

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	290	$8,450
2016	360	2,521	$124,925
2017	675	4,707	$288,309
2018	816	6,162	$480,969
2019	852	5,727	$491,880
2020	928	6,585	$628,480
2021	916	6,672	$710,115
2022	995	6,508	$739,916
2023	1,164	8,322	$1,063,798
2024	1,268	9,583	$1,291,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	550	623	$78
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	143	235	$55
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	550	560	$45
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	139	140	$10
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	265	268	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	536	28,577	$545,702
Entresto	Sacubitril/Valsartan	197	9,262	$195,423
Xarelto	Rivaroxaban	165	8,220	$149,102
Jardiance	Empagliflozin	84	3,368	$66,994
Repatha Sureclick	Evolocumab	51	2,522	$49,396

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$1,108	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yuba Raj Acharya, M.D.?

Tedicare shows public-source Medicare data for Yuba Raj Acharya, M.D. (NPI 1376716290), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yuba Raj Acharya, M.D. have ACO affiliation data?

Yuba Raj Acharya, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and CommonSpirit ACO III (MSSP, ACO ID A2645).

What billing organization is linked to Yuba Raj Acharya, M.D.?

Yuba Raj Acharya, M.D. is linked to CHI ST. VINCENT MEDICAL GROUP HOT SPRINGS (billing NPI 1831387117) in the available physician profile data.

Does Yuba Raj Acharya, M.D. have Open Payments data?

Yuba Raj Acharya, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.